{
    "clinical_study": {
        "@rank": "126014", 
        "arm_group": [
            {
                "arm_group_label": "Low-dose pain medication", 
                "arm_group_type": "Active Comparator", 
                "description": "80min IV infusion of a low-dose pain medication"
            }, 
            {
                "arm_group_label": "saline placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "80min IV infusion of a saline placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine how pain relief is modified when the investigators\n      combine the Virtual Reality based Snow World game with certain pain medications."
        }, 
        "brief_title": "Modifying Virtual Reality Analgesia With Low-Dose Pain Medication", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Virtual Reality Therapy", 
        "detailed_description": {
            "textblock": "This is a randomized, double-blind, placebo-controlled, within subject 2x2 factorial,\n      repeated measures study. Research participants will play two versions of the Virtual Reality\n      based video game \"Snow World\" and be given thermal and electrical stimulus. Each of two\n      study visits will be identical with the exception of whether or not the participant will\n      receive an iv infusion of a low dose pain medication or a saline placebo."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male and females between the age of 18 and 60 years\n\n          -  Ability to communicate orally\n\n          -  Ability to read and understand English\n\n          -  Body Mass Index between 20-35\n\n        Exclusion Criteria:\n\n          -  Women who are pregnant, trying to become pregnant, or who are breastfeeding\n\n          -  History of alcohol or substance abuse\n\n          -  Major medical illness; including history of migraine headaches, seizures, brain\n             injury, or peripheral neuropathy\n\n          -  Current use of analgesics including acetaminophen, non-steroidal anti-inflammatories,\n             or opioids\n\n          -  Predisposition to severe motion sickness\n\n          -  Unusual sensitivity or lack of sensitivity to pain\n\n          -  Urine toxicology positive for opioids or benzodiazepines"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840774", 
            "org_study_id": "43929"
        }, 
        "intervention": {
            "arm_group_label": [
                "Low-dose pain medication", 
                "saline placebo"
            ], 
            "intervention_name": "Low-dose pain medication (Ketalar) and saline placebo", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Analgesics"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 25, 2013", 
        "location": {
            "contact": {
                "email": "hoffer@uw.edu", 
                "last_name": "Christine Hoffer, BA", 
                "phone": "206-616-3075"
            }, 
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98195"
                }, 
                "name": "University of Washington"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Modifying Virtual Reality Analgesia With Low-Dose Pain Medication", 
        "overall_contact": {
            "email": "hoffer@uw.edu", 
            "last_name": "Christine Hoffer, BA", 
            "phone": "206-616-3075"
        }, 
        "overall_official": {
            "affiliation": "University of Washington", 
            "last_name": "Samuel Sharar, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pain responses between placebo and the low-dose pain medication while playing Snow World. We will assess pain responses with subjective questionnaires concerning the participant's experience while playing Snow World.", 
            "safety_issue": "No", 
            "time_frame": "Conclusion of 120 study visits. Each participant will spend a total of 8 hours with us."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840774"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Washington", 
            "investigator_full_name": "Sam Sharar", 
            "investigator_title": "Study Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Washington", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institutes of Health (NIH)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Washington", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}